Functionalizing silica sol-gel with entrapped plant virus-based immunosorbent nanoparticles.
Antibody purification
Biosensing
Bioseparations
Molecular pharming
Monoclonal antibody
Nanobiotechnology
Plant-made pharmaceuticals
Silica sol–gel
Tobamovirus
Virus-based nanomaterial
Journal
Journal of nanobiotechnology
ISSN: 1477-3155
Titre abrégé: J Nanobiotechnology
Pays: England
ID NLM: 101152208
Informations de publication
Date de publication:
04 Mar 2022
04 Mar 2022
Historique:
received:
16
11
2021
accepted:
08
02
2022
entrez:
5
3
2022
pubmed:
6
3
2022
medline:
1
4
2022
Statut:
epublish
Résumé
Advancements in understanding and engineering of virus-based nanomaterials (VBNs) for biomedical applications motivate a need to explore the interfaces between VBNs and other biomedically-relevant chemistries and materials. While several strategies have been used to investigate some of these interfaces with promising initial results, including VBN-containing slow-release implants and VBN-activated bioceramic bone scaffolds, there remains a need to establish VBN-immobilized three dimensional materials that exhibit improved stability and diffusion characteristics for biosensing and other analyte-capture applications. Silica sol-gel chemistries have been researched for biomedical applications over several decades and are well understood; various cellular organisms and biomolecules (e.g., bacteria, algae, enzymes) have been immobilized in silica sol-gels to improve viability, activity, and form factor (i.e., ease of use). Here we present the immobilization of an antibody-binding VBN in silica sol-gel by pore confinement. We have shown that the resulting system is sufficiently diffuse to allow antibodies to migrate in and out of the matrix. We also show that the immobilized VBN is capable of antibody binding and elution functionality under different buffer conditions for multiple use cycles. The promising results of the VBN and silica sol-gel interface indicate a general applicability for VBN-based bioseparations and biosensing applications.
Identifiants
pubmed: 35246160
doi: 10.1186/s12951-022-01303-1
pii: 10.1186/s12951-022-01303-1
pmc: PMC8895542
doi:
Substances chimiques
Gels
0
Immunosorbents
0
Silica Gel
60650-90-0
Silicon Dioxide
7631-86-9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105Subventions
Organisme : NASA
ID : 80NSSC18K1157
Pays : United States
Organisme : NASA
ID : NNX17AJ31G
Pays : United States
Organisme : NASA
ID : NNX16AO69A
Pays : United States
Organisme : National Science Foundation
ID : 1806366
Informations de copyright
© 2022. The Author(s).
Références
Adv Mater. 2014 Aug 6;26(29):4961-4966
pubmed: 24711251
J Biol Chem. 1951 May;190(1):55-9
pubmed: 14841150
J Phys Chem B. 2017 Mar 9;121(9):2121-2126
pubmed: 28182856
Nat Mater. 2002 Sep;1(1):42-4
pubmed: 12618847
J Mater Chem B. 2014 Nov 14;2(42):7440-7448
pubmed: 32261969
Adv Ther (Weinh). 2021 Aug;4(8):
pubmed: 34541299
Sci Rep. 2016 Mar 31;6:23803
pubmed: 27030058
Anal Chem. 2004 May 15;76(10):2780-90
pubmed: 15144188
Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14701-6
pubmed: 16973752
Langmuir. 2014 Aug 19;30(32):9780-8
pubmed: 25062385
Macromol Biosci. 2016 Feb;16(2):231-41
pubmed: 26440117
Biosens Bioelectron. 2015 May 15;67:321-6
pubmed: 25201014
Annu Rev Virol. 2015 Nov;2(1):379-401
pubmed: 26958921
Methods Mol Biol. 2011;679:49-66
pubmed: 20865388
Gene Ther. 2009 Jan;16(1):103-10
pubmed: 18754041
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17678-83
pubmed: 17090664
Nanoscale. 2017 Jan 26;9(4):1580-1590
pubmed: 28070572
PLoS One. 2018 Feb 6;13(2):e0192455
pubmed: 29408944
Chem Soc Rev. 2016 Jul 25;45(15):4074-126
pubmed: 27152673
Methods Mol Biol. 2014;1108:173-85
pubmed: 24243249